Key facts
- This page summarizes Malcolm P. Fairbairn's Form 4 filing for TFF Pharmaceuticals, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 May 2021, 16:05.
Malcolm P. Fairbairn - 19 May 2021 Form 4 Insider Report for TFF Pharmaceuticals, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 19 May 2021
- Net transaction value
- +$89,500
- Reporting owner signature
- /s/ Malcolm P. Fairbairn
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Malcolm P. Fairbairn filed Form 4 for TFF Pharmaceuticals, Inc. on 19 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$89,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TFFP
transaction
Common Stock
Purchase
- Transaction value
- $89,500
- Shares
- +10,000
- Change %
- Price
- $8.95
- Shares after
- 10,000
- Date
- 19 May 2021
- Ownership
- By Valley High, LP
TFFP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,317,568
- Date
- 19 May 2021
- Ownership
- By Maestro Ventures Partners, LP
* marks a reported price that did not pass the local price check.